Home > Boards > US Listed > Cannabis > InMed Pharmaceuticals Inc. (INM)

You are 100% correct.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Artillery0842 Member Profile
 
Followed By 3
Posts 762
Boards Moderated 0
Alias Born 07/26/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/20/2021 3:44:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2021 2:43:41 PM
InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe PR Newswire (Canada) - 1/19/2021 2:00:00 PM
InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe PR Newswire (US) - 1/19/2021 2:00:00 PM
InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire (US) - 1/8/2021 7:30:00 AM
InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire (Canada) - 1/8/2021 7:30:00 AM
InMed to Participate at Virtual Conferences in January 2021 PR Newswire (US) - 1/5/2021 4:52:00 PM
InMed to Participate at Virtual Conferences in January 2021 PR Newswire (Canada) - 1/5/2021 4:52:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 6:22:27 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 6:21:18 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 6:19:14 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 6:18:36 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 6:17:24 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 6:16:19 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 12/17/2020 6:04:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/4/2020 1:49:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/3/2020 12:59:49 PM
InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids PR Newswire (US) - 12/3/2020 7:30:00 AM
InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids PR Newswire (Canada) - 12/3/2020 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2020 10:50:03 AM
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire (Canada) - 11/25/2020 7:30:00 AM
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects PR Newswire (US) - 11/25/2020 7:30:00 AM
InMed Announces Election of Directors PR Newswire (Canada) - 11/24/2020 8:00:00 PM
InMed Announces Election of Directors PR Newswire (US) - 11/24/2020 8:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/18/2020 12:32:11 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences